Closed transaction
- Advised by
- Deal stage
- Closed transaction
- Service
- Sell
- Sector
- Healthcare
- Sub-sector
- Biotech/Pharma Services
- Contact
- chang@kudos.co.kr
Deal details
The second largest major shareholder of Ildong Pharm sold its holding 29% shares to H&Q, private equity firm, at KRW 140bn.
Kudos Financial Services Group Co. Ltd. latest deals
Advisory
Eugene Private equity was sold to Inovance.
- Year
- 2023
Buy-side advisory
Ildong Holdings acquired a stake in H&Q Asia Pacific.
- Year
- 2019
Equity advisory
Medit Corp raised capital from Premier Partners & Ryukyung PSG Asset Management (Financial Investors).
- Year
- 2019
Sell-side advisory
ILDONG HOLDINGS CO., LTD. acquired a stake in Private Investor.
- Year
- 2019
More deals in Healthcare
Sell-side advisory
NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.
- Adviser
- INEO Corporate
- Where
- Spain
- Year
- 2026
Sell-side advisory
PharmaX Solutions was sold to BioPhorum.
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2026
Sell-side advisory
Nostos Genomics was sold to Limbus Medical Technologies (varvis®).
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2025
Sell-side advisory
3iM Healthcare AB acquired Avia Pharma.
- Adviser
- Evli Corporate Finance AB
- Where
- Finland
- Year
- 2025
More deals in Asia-Pacific
Membership
Gain worldwide reach with CapFive M&A professionals
The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.
Become a member